Collaborations with the Industry
Since 2000 our unit has actively participated in a number of multicenter clinical trials supported by funding agencies, the administration of which was carried out mostly through the Research Committee of the University of Thessalia. The projects are presented in the following table:
Year | Company | Title |
|---|---|---|
2001 | ZIMMER - ARTHROSIS | Integration of acetabular prosthesis on tantalium uncemented Hip Arthroplasty. |
2001 | NOVARTIS | An international, multicenter, stratifier, randomized, double-blind, double-dummy, parallel-group, 52-week gastrointestinal clinical safety study to demonstrate that COX189 (400mg od) reduces the risk to develop complicated ulcers as compared to NSAIDs (naproxen 500 mg bid and ibuprofen 800 mg tid), in osteoarthritis patients. |
2001-2002 | ZIMMER Ltd | A Clinical Outcome Study: |
2002 | BOEHRINGER INGELHEIM | The influence of non-steroidal anti- infammatory drugs on fracture union. |
2002 | NOVARTIS | Distal Radius fractures and Calcitonin. |
2002 | Various Sponsors | Research protocol on Hand Fractures. |
2002 | IMPLEX CORP. – New Jersey, USA | HEDROCEL Trabecular Metal Technology of IMPLEX |
Various Sponsors | Maintenance – functional outcome of the Arthroplasty of the Hip and Knee. | |
Various Sponsors | The relevance of the expansion of the lesion in avascular necrosis of the femoral head with the clinical outcome. Three dimensional analysis and estimation of the volume of the lesion with the ANALYZE system. | |
2002 | ZIMMER Ltd | Porous Tantalum (Trabecular Metal) implants for femoral head osteonecrosis: (a) the Acetabular metal ring, (b) the Intra-lesion implant. |
2004 | SANOFI SYNTHELABO | EXPERT: C8843 |
2004 | SANOFI SYNTHELABO | A prospective, uncontrolled, multi-centre, post-marketing surveillance study to evaluate the long-term performance of summit tapered Hip in Cemented Total Hip Arthroplasty. |
2004 | NOVARTIS | CZOL446H 2310: A multinational, multicentre, multiple-dose, randomized, double-blind, double dummy, parallel group study with a long term open-label extension phase for the evaluation of the zoledronic acid in the prevention of future osteoporotic hip fractures. |
2004-2005 | VIANEX | A double-blind, parallel-group, 4-week trial to assess the efficacy and safety of Etoricoxib 60 mg and Diclofenac 150 mg in patients with Chronic Low Back Pain. |
2006 | Various Sponsors | Use of ultrasound for the enhancement of healing of Cartilage Tissues. |
2006 | NOVARTIS AE | The effect of the calcitonin administration on the healing of fracture and osteopenia of the patient, in patients with fractures in the periphery of the fibula. |
2006 | ROCHE (HELLAS) A.E. | BEATRIS study: A randomized, open, multinational study of the effect of information related to osseous markers (in a two-month period) in the total compliance in the monthly treatment with ibandronate acid in postmenopausal osteoporosis. |
2007 | SANOFI AVENTIS | Trek – DRI 6243: a multi-centre, randomized, double-blind, double-dummy, parallel group dose-response study of subcutaneous AVE 5026 with an enoxaparin calibrator arm in the prevention of Venous Thromboembolism in patients undergoing Elective Total Knee Replacement Surgery. |
2007 | NOVARTIS Hellas AEBE | Eu-CORESM: European CUBICIN® Outcomes Registry and Experience for the Treament of Serious Gram-positive Infections. |
2007 | SANOFI AVENTIS Hellas | ETHOS Clinical Trial: |
2007 | SANOFI AVENTIS AEBE | Clinical Trial EFC 10343 – SAVE HIP 2: |
2007 | DEPUY | A prospective, international, multi-centre, uncontrolled, post- marketing surveillance study to monitor the long-time performance of a large Metal-on-Metal (MoM) bearing comprising a DePuy ASRTM cup in conjunction with either a DePuy ASRTM hip resurfacing femoral component or a DePuy ASR TM XL Head in subjects with indications suitable for either a primary resurfacing arthroplasty or primary Total Hip Arthroplasty. |
2008 | NYCOMED Danmark, Aps | PAREXEL Number: 90383 |
2008 | PHARMASERVE- LILLY | B3D-EW-GHDK (EudraCT: 2008-002693-35) A comparison of the effect of Teriparatide with that of Risedronate in the bone density of the lumbar spine in men and postmenopausal women with low bone mass and a recent intertrochanteric fracture. |
